A Double-Blind, Placebo-Controlled, Randomized Study: 16-Week Evaluation of the Efficacy and Safety of Levetiracetam (LEV) as Add-on Therapy in Adults and Adolescents Older Than 16 Years Suffering From Partial Seizures.
Phase of Trial: Phase III
Latest Information Update: 30 Oct 2014
At a glance
- Drugs Levetiracetam (Primary)
- Indications Partial epilepsies
- Focus Registrational; Therapeutic Use
- Sponsors UCB Pharma Inc
- 15 Sep 2009 Additional lead trial investigator Shally Y identified as reported by ClinicalTrials.gov.
- 16 Jul 2007 Status changed from in progress to completed.
- 20 Nov 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History